DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Marinus - 1 Biomea - 1
Top related locs:
Top related orgs:
Citi - 1 Federal Reserve - 1 CNBC Pro - 1 Biotechnology - 1 P Biotech ETF - 1 Marinus Pharmaceuticals - 1 Olema Pharmaceuticals - 1 Ovid Therapeutics - 1

Search resuls for: "Ovid Therapeutics"


3 mentions found


☆ Analysts love these biotech stocks, giving 4 more than 100% upside
  + stars: | 2024-01-25 | by ( Weizhen Tan | ) www.cnbc.com   time to read: +2 min
To look for biotech stocks that did well last year and that analysts are still positive on, CNBC Pro screened the iShares Biotechnology ETF and the SPDR S & P Biotech ETF. Potential upside to average price target of more than 40%. Four stocks stood out for being given on average more than 100% potential upside: Humacyte , Marinus Pharmaceuticals , Olema Pharmaceuticals and Ovid Therapeutics . Another three stocks in the screen drew 100% buy ratings from analysts: Ardelyx , Cabaletta Bio and Rocket Pharmaceuticals . Of these three, Rocket Pharmaceuticals got the highest potential upside of 81.4%.
Persons: Marinus, Biomea Organizations: Citi, Federal Reserve, CNBC Pro, Biotechnology, P Biotech ETF, Marinus Pharmaceuticals, Olema Pharmaceuticals, Ovid Therapeutics, Rocket Pharmaceuticals
☆ Pfizer, hundreds of US drugmakers call for reversal of Texas abortion pill ruling
  + stars: | 2023-04-10 | by ( Michael Erman Ahmed Aboulenein | Michael Erman | Ahmed Aboulenein | ) www.reuters.com   time to read: +3 min
[1/4] A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/IllustrationApril 10 (Reuters) - Over 300 biotech and pharmaceutical industry executives, including Pfizer Inc (PFE.N) CEO Albert Bourla, signed an open letter on Monday calling for reversal of a federal judge's decision to suspend sales of the abortion pill mifepristone. Last week's ruling by Judge Matthew Kacsmaryk undermines the FDA's authority, the letter's authors wrote, adding that it ignores decades of scientific evidence and legal precedent. The ruling could open the possibility to the banning of vaccines and contraception for women, said Levin. "It's the single worst threat to the industry in over 50 years."
☆ WHO 'strongly advises against' use of two COVID treatments
  + stars: | 2022-09-15 | by ( Natalie Grover | ) www.reuters.com   time to read: +3 min
A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. The virus has since evolved, and mounting evidence from lab tests suggests the two therapies - sotrovimab as well as casirivimab-imdevimab - have limited clinical activity against the latest iterations of the virus. Another COVID therapy that emerged early in pandemic was Gilead's (GILD.O) antiviral remdesivir. The WHO expanded its conditional recommendation for the drug, advising that it can be used in patients with severe COVID as well as non-severe COVID patients at the highest risk of hospitalization. There are a handful of existing COVID therapeutics that remain useful in the fight against the virus, and others in development that are expected to also benefit patients.
0 next >>
Total: 3